MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,973,177 | $71,390,000 | 7.90% |
| Tieton Capital Management, LLC | 251,143 | $9,086,000 | 7.81% |
| Summit Street Capital Management, LLC | 137,111 | $4,961,000 | 5.67% |
| Camber Capital Management LP | 2,000,000 | $72,360,000 | 4.59% |
| S&T BANK/PA | 487,501 | $17,637,000 | 3.15% |
| FCF Advisors LLC | 11,798 | $427,000 | 1.33% |
| AIMZ Investment Advisors, LLC | 43,885 | $1,588,000 | 1.30% |
| Millrace Asset Group, Inc. | 32,738 | $1,184,000 | 1.11% |
| Lisanti Capital Growth, LLC | 46,150 | $1,670,000 | 1.05% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,348,107 | $48,775,000 | 1.02% |